Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus

Cristofanilli, 2004, Circulating tumor cells, disease progression, and survival in metastatic breast cancer, N Engl J Med, 351, 781, 10.1056/NEJMoa040766 Danila, 2011, Circulating tumor cells as biomarkers in prostate cancer, Clin Cancer Res, 17, 3903, 10.1158/1078-0432.CCR-10-2650 Lianidou, 2013, Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer, Br J Cancer, 108, 2426, 10.1038/bjc.2013.265 Kang, 2013, Tumor cell dissemination: emerging biological insights from animal models and cancer patients, Cancer Cell, 23, 573, 10.1016/j.ccr.2013.04.017 Nagrath, 2007, Isolation of rare circulating tumour cells in cancer patients by microchip technology, Nature, 450, 1235, 10.1038/nature06385 Androulakis, 2012, Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer, Br J Cancer, 106, 1917, 10.1038/bjc.2012.202 Königsberg, 2011, Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients, Acta Oncol, 50, 700, 10.3109/0284186X.2010.549151 Rao, 2005, Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors, Int J Oncol, 27, 49 Zhang, 2013, The identification and characterization of breast cancer CTCs competent for brain metastasis, Sci Transl Med, 5, 180ra48, 10.1126/scitranslmed.3005109 Kojima, 2009, A simple biological imaging system for detecting viable human circulating tumor cells, J Clin Invest, 119, 3172, 10.1172/JCI38609 Takakura, 2012, Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers, Br J Cancer, 107, 448, 10.1038/bjc.2012.276 Kishimoto, 2006, In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus, Nat Med, 12, 1213, 10.1038/nm1404 Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation, Science, 303, 83, 10.1126/science.1091903 Sieuwerts, 2011, mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients, Clin Cancer Res, 17, 3600, 10.1158/1078-0432.CCR-11-0255 Vincent, 2009, A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition, Nat Cell Biol, 11, 943, 10.1038/ncb1905 Anders, 2009, Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression, Br J Cancer, 100, 352, 10.1038/sj.bjc.6604876 Yokobori, 2013, Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis, Cancer Res, 73, 2059, 10.1158/0008-5472.CAN-12-0326 Gaggar, 2003, CD46 is a cellular receptor for group B adenoviruses, Nat Med, 9, 1408, 10.1038/nm952 Bjørge, 1997, Complement-regulatory proteins in ovarian malignancies, Int J Cancer, 70, 14, 10.1002/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3.0.CO;2-9 Varela, 2008, Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection, Int J Cancer, 123, 1357, 10.1002/ijc.23676 Mizuguchi, 2005, Efficient regulation of gene expression using self-contained fiber-modified adenovirus vectors containing the tet-off system, J Control Release, 110, 202, 10.1016/j.jconrel.2005.09.008 Sakurai, 2005, Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities, Gene Ther, 12, 1424, 10.1038/sj.gt.3302562 Hashimoto, 2008, Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus, Cancer Sci, 99, 385, 10.1111/j.1349-7006.2007.00665.x Sakurai, 2007, Downregulation of human CD46 by adenovirus serotype 35 vectors, Gene Ther, 14, 912, 10.1038/sj.gt.3302946 Friedlander, 2014, Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer, Int J Cancer, 134, 2284, 10.1002/ijc.28561 Li, 2013, Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease, Cell Death Dis, 4, e831, 10.1038/cddis.2013.347 Yu, 2013, Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition, Science, 339, 580, 10.1126/science.1228522 Nadal, 2013, CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy, Int J Cancer, 133, 2398, 10.1002/ijc.28263 Kasimir-Bauer, 2012, Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells, Breast Cancer Res, 14, R15, 10.1186/bcr3099 Baccelli, 2013, Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay, Nat Biotechnol, 31, 539, 10.1038/nbt.2576 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA, 100, 3983, 10.1073/pnas.0530291100 Dorsey, 2015, Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results, Cancer, 121, 139, 10.1002/cncr.28975 Lou, 2013, Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR, PLoS One, 8, e80458, 10.1371/journal.pone.0080458 Huang, 1995, Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery, J Virol, 69, 2257, 10.1128/JVI.69.4.2257-2263.1995 Leon, 1998, Adenoviral-mediated gene transfer in lymphocytes, Proc Natl Acad Sci USA, 95, 13159, 10.1073/pnas.95.22.13159 Demirci, 2009, Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma?, Asian Pac J Cancer Prev, 10, 1021 Vasiliades, 2012, Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer, Int J Biol Markers, 27, e186, 10.5301/JBM.2012.9348 Weng, 1996, Regulated expression of telomerase activity in human T lymphocyte development and activation, J Exp Med, 183, 2471, 10.1084/jem.183.6.2471 Igarashi, 1997, Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor, Blood, 89, 1299, 10.1182/blood.V89.4.1299 Wang, 2011, Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14, Nat Med, 17, 96, 10.1038/nm.2270 Chen, 2011, Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition, Mol Cell Proteomics, 10, 10.1074/mcp.M110.001131 Koizumi, 2003, Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob, J Gene Med, 5, 267, 10.1002/jgm.348 Dmitriev, 1998, An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism, J Virol, 72, 9706, 10.1128/JVI.72.12.9706-9713.1998 Wickham, 1997, Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins, J Virol, 71, 8221, 10.1128/JVI.71.11.8221-8229.1997 Lo, 2011, Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival, J Clin Pathol, 64, 153, 10.1136/jcp.2010.087478 Shinyo, 2005, Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer, Gynecol Oncol, 96, 776, 10.1016/j.ygyno.2004.11.004 Smirnov, 2005, Global gene expression profiling of circulating tumor cells, Cancer Res, 65, 4993, 10.1158/0008-5472.CAN-04-4330 Merkerova, 2008, Differential expression of microRNAs in hematopoietic cell lineages, Eur J Haematol, 81, 304, 10.1111/j.1600-0609.2008.01111.x Brown, 2006, Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer, Nat Med, 12, 585, 10.1038/nm1398 Brown, 2007, Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state, Nat Biotechnol, 25, 1457, 10.1038/nbt1372 Huang, 2009, miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA, EMBO Rep, 10, 180, 10.1038/embor.2008.224 Ding, 2012, Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus, Arthritis Rheum, 64, 2953, 10.1002/art.34505 MacKenzie, 2013, Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation, Mol Cancer Ther, 12, 1266, 10.1158/1535-7163.MCT-12-1231 Kawashima, 2004, Telomerase-specific replication-selective virotherapy for human cancer, Clin Cancer Res, 10, 285, 10.1158/1078-0432.CCR-1075-3 Mizuguchi, 1999, A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors, Hum Gene Ther, 10, 2013, 10.1089/10430349950017374 Sakurai, 2003, Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector, Gene Ther, 10, 1041, 10.1038/sj.gt.3301959 Mizuguchi, 2001, In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors, Biotechniques, 30, 1112, 10.2144/01305dd03 Mizuguchi, 2005, Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells, Biochem Biophys Res Commun, 332, 1101, 10.1016/j.bbrc.2005.05.055